Differences in beta-glucan levels in culture supernatants of a variety of fungi

References

• Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am 2002; 16: 915–933
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909–917
   PubMed Web of Science ®Google Scholar
• Morrison VA, Haake RJ, Weisdorf DJ. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore) 1993; 72: 78–89
   PubMedGoogle Scholar
• Ponton J, Ruchel R, Clemons KV, et al. Emerging pathogens. Med Mycol 2000; 38: 225–236
   PubMed Web of Science ®Google Scholar
• Silveira F, Nucci M. Emergence of black moulds in fungal disease: epidemiology and therapy. Curr Opin Infect Dis 2001; 14: 679–684
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis 1999; 1: 247–261
   PubMedGoogle Scholar
• Aisner J, Wiernik PH, Schimpff SC. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Int Med 1977; 86: 539–543
   PubMed Web of Science ®Google Scholar
• Ohki M, Nakamura T, Morita T, Iwanaga S. A new endotoxin sensitive factor associated with hemolymph coagulation system of horseshoe crab (Limulidae). FEBS Lett 1980; 120: 217–220
   PubMedGoogle Scholar
• Morita T, Tanaka S, Nakamura T, Iwanaga S. A new (1-3)-ß-D-glucan-mediated coagulation pathway found in limulus amebocytes. FEBS Lett 1981; 129: 318–321
   Web of Science ®Google Scholar
• Miyazaki T, Kohno S, Mitsutake K, et al. (1→3)-beta-D-glucan in culture fluid of fungi activates factor G, a limulus coagulation factor. J Clin Lab Anal 1995; 9: 334–339
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199–205
   PubMed Web of Science ®Google Scholar
• Obayashi T, Yoshida M, Mori T, et al. Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17–20
   PubMed Web of Science ®Google Scholar
• Mitsutake K, Kohno S, Miyazaki T, et al. Detection of (1-3)-beta-D-glucan in a rat model of aspergillosis. J Clin Lab Anal 1995; 9: 119–122
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Kohno S, Mitsutake K, et al. Plasma (1-3)-b-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 1995; 33: 3115–3118
   PubMed Web of Science ®Google Scholar
• Yoshida M, Obayashi T, Iwama A, et al. Detection of plasma (1-3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces, and Acremonium fungaemias. J Med Vet Mycol 1997; 35: 371–374
   PubMedGoogle Scholar
• Yuasa K, Goto H, Iguchi M, Okamura T, Ieki R. Evaluation of the diagnostic value of the measurement of (1-3)-beta-D-glucan in patients with pulmonary aspergillosis. Respiration 1996; 63: 78–83
   Google Scholar
• Morimoto S, Shimazaki C, Goto H, et al. Trichosporon cutaneum fungemia in patients with acute myeloblastic leukemia and measurement of serum D-arabinitol, Candida antigen (CAND-TEC), and beta-D-glucan. Ann Hematol 1994; 68: 159–161
   Google Scholar
• Jojima H. Early diagnosis and treatment of pulmonary opportunistic infection by using polymerase chain reaction and beta-glucan in patients with hematological neoplasms. Kurume Med J 2001; 48: 117–127
   PubMedGoogle Scholar
• Saeki F, Ridge RJ, Finkelman MA, Ketchum PA, Rex JH. Application of a glucan-specific Limulus amebocyte lysate serum assay for diagnosis of invasive fungal infections. In: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; 2001; abstract 841.
   Google Scholar
• Mori T, Matsumura M. Clinical evaluation of diagnostic methods using plasma and/or serum for three mycoses: aspergillosis, candidosis, and pneumocystosis. Nippon Ishinkin Gakkai Zasshi 1999; 40: 223–230
   PubMedGoogle Scholar
• Mori T, Ikemoto H, Matsumura M, et al. Evaluation of plasma (1→3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clinl Chem Clin Biochem 1997; 35: 553–560
   PubMedGoogle Scholar